INTRODUCTION TO RA.

Slides:



Advertisements
Similar presentations
The Role of Government in Encouraging a High Standard of Ethics in the Healthcare Sector: Indonesia Experience Prof. Agus Purwadianto Senior Adviser to.
Advertisements

The Statisticians Role in Pharmaceutical Development
10 th October 2013 The delivery of 21 st century services – the implications for the evolution of the Healthcare Science workforce Joan Fletcher.
STATISTICS DEFINITION AND MEANING
UNITED SPINAL ASSOCIATION AUGUST, 2014 Biologics & Biosimilars: An Overview 1.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
CORE COMPETENCIES IN CLINICAL & TRANSLATIONAL RESEARCH: The Child Health Perspective I. Clinical & Translational Research Questions: Extract information.
Introduction to Regulation
PARMEE DEDHIA M.Pharm (Clinical Pharmacy), NMIMS
S ocial scientists are interested in how different innovative medical technologies including human tissue engineered products (HTEPs) fit into the changing.
Health and Medical Science Nick Besley Manager, Marketing and Communications, Science, Engineering and Health.
What Do Toxicologists Do?
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
1. 0ur story 8 of the top 10 Pharmaceutical companies are located in Ireland. 12 out of the top 25 selling drugs are produced in Ireland Exported €50.8.
Careers in Biomedical Engineering Technology BMET 4350 Fall 2003 Dr. Hugh Blanton.
LIMITLESS POTENTIAL | LIMITLESS OPPORTUNITIES | LIMITLESS IMPACT Copyright University of Reading IMPACT AND THE SCIENCES Anthony Atkin (Research Impact.
Career Opportunities in Statistics John Borkowski Montana State University Panel Discussion Pattaya Conference on Statistics Pattaya, Thailand.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
WHERE WE ARE 22 member associations in 20 countries Over 4300 individual members who are responsible for risk management and/or insurance in their organisations.
National Medicine Policy
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
Patient Safety and Medical Devices Sonia Swayze, RN, MA, C and Suzanne Rich, RN, MA, CT.
A M I L C A R AMI LCA R Advice in Medical Investigation and Logistics for Communication And Research The Universitary-linked.
Stefan Franzén Introduction to clinical trials.
Drug Submissions: Review Process Agnes V. Klein, MD Biologics and Genetic Therapies Directorate February, 2003 www/hc-sc.gc.ca/hpb-dgps/therapeut.
Clinical Pharmacy Part 2
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. REGULATORY INTELLIGENCE: INDUSTRY’S BEST PRACTICE OMICS 5 th International Pharmaceutical.
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
1 Post-Genomics and the Future of Human Societies: a Foresight Approach Excerpts from “ DNA Analysis for Human Health in the Post- Genomic Era - An APEC-wide.
Important informations
PERFORMANCE OF VETERINARY STATUTORY BODIES CURRENT SITUATION AND EVOLUTION IN BRAZIL.
Graduate studies - Master of Pharmacy (MPharm) 1 st and 2 nd cycle integrated, 5 yrs, 10 semesters, 300 ECTS-credits 1 Integrated master's degrees qualifications.
Developing medicines for the future and why it is challenging Angela Milne.
The FDA Regulatory and Compliance Symposium Preparing for the FDA’s Risk-Based Inspections Presented By: Martin Browning, EduQuest, Inc.
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Nanotechnology - USDA - 18 Nov 2002 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D.
Marketing Career Project Renee Bass Pharmaceutical/Medical Marketing.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Chapter Dental Public Health & Research Contemporary Practice for the Dental Hygienist Copyright ©2011 by Pearson Education, Inc. All rights reserved.
FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 22-23, 2008 Introduction and Update Helen N. Winkle Director, Office of.
E-Clinical
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
GCP (GOOD CLINICAL PRACTISE)
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
Regulatory Affairs Certification (RAC) Global Scope Exam Pass RAC (Regulatory Affairs Certification) in first attempt By the help of Exams4sure.netExams4sure.net.
PHARMA HELPLINE SOCIETY we care,we assist, we help Announces on line courses for the overall development of pharmacy professionals and students. These.
INTRODUCTION TO DRUG REGULATORY AFFAIRS. Regulatory Affairs ???  Regulatory Affairs is a comparatively new profession which has developed from the desire.
RAC Regulatory Affairs Certification
CLINICAL TRIALS.
FDA's Two New Draft Guidance on Software and Device
Impact and the Physical Sciences
Contract Research organizations
Recent Evolution of New Drug Review and Approval System in Korea
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.
Introduction to Clinical Pharmacy
Pharmacist- Career Opportunities
AIKTC - School of Pharmacy
Beyond Academia.
The Evolving Role Of Medical Affairs (MA)
Code of Ethics for CDM Professionals
Code of Ethics for CDM Professionals
Clinical Research Services.  It is very important phase in medical science as it determines the safety and effectiveness of medications and treatment.
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
Saudi Arabia: Veterinary Pharmaceutical Legislations &
Presentation transcript:

INTRODUCTION TO RA

OVERVIEW What is Regulatory Affairs ? Other Functional Areas of Interest Who are Regulatory Professionals? Why consider a career in Regulatory Affairs? The future of Regulatory Affairs

Why Regulatory Affairs? Medicinal Products are a very specialized form of consumer product They must be safe, effective and suitable for their intended purpose Pharmaceutical manufacturers must satisfy themselves, the regulatory authorities, the medical profession and patients that their products are safe and suitable Canadian pharmaceutical industry is regulated by Health Canada

What is Regulatory Affairs? Profession within regulated industries, such as pharmaceuticals, biopharmaceuticals, medical devices, cosmetics and consumer health, natural health and veterinary products Regulatory Affairs is the department within the company that interacts with the government authorities who regulate the activities of the company (e.g. Health Canada)

What does a Regulatory Professional Do? Keep track of changing legislation in regions where the company distributes its products Interpret and apply regulations Advise internal colleagues on legal and scientific requirements Develop and implement regulatory strategies Collect, collate and evaluate scientific data Prepare submissions to regulatory agencies such as Health Canada, FDA (US), EMA (Europe) and in other jurisdictions Participate in product development programs to ensure adherence to international regulations and guidelines

Other Functional Areas of Interest RA professionals interact with numerous functional areas: Pre-Clinical Research Pharmacology and Toxicology testing to evaluate new drug candidates Clinical Research Conduct of clinical studies, data collection, statistical analysis, report writing Manufacturing High levels of controls for production of safe and efficacious products Quality Control Analytical testing of all product lots for purity, potency, safety, quality Quality Assurance Oversight of operations related to failure investigations, auditing, recalls, complaints, documentation management

Other Functional Areas of Interest RA professionals interact with numerous functional areas: Sales and Marketing Review and approval of advertising materials and communications for new product launches Legal (Intellectual Property) Project Management Team Managing complex, multi-functional projects

Why is Regulatory Affairs Important? RA is the point of contact between the company and regulatory authorities Attitudes and actions of RA contribute to how the health authorities perceive the company overall RA professionals play a critical role in the reduction of time taken for a product to reach the market, and take steps to ensure the products remain on the market Contributes to company success Economically important for the company

Who are Regulatory Professionals RA professionals are generally graduates of scientific disciplines Skill set of a successful RA professional: project management communication skills negotiation skills analytical skills presentation skills Strong ethics / integrity Good judgement

Why Consider a Career in Regulatory Affairs? Environment of continuous learning and growth (e.g., changing laws and science) Work in a business sector that is involved in the evolution of scientific knowledge Work with colleagues in a variety of functional areas such as pharmacologists, chemists, medical doctors, engineers, lawyers Work in an area that can influence health and well-being of millions of people

The Future of Health Care Aging population People living longer lives Increased consumer demand for medical interventions due to availability of information (internet)

The Future of Regulatory Affairs New technologies will drive industry growth Stem cell therapies Nanotechnology Personalized medicine will allow medicines to be tailored to patients’ needs based on their genetic profile Gene therapies Increased diagnostic capabilities